Spatially fractionated (GRID) therapy for large and bulky tumors.

José A. Peñagarícano, Robert Griffin, Peter Corry, Eduardo Moros, Yulong Yan, Vaneerat Ratanatharathorn

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Avanced bulky tumors warrant aggressive therapy to attempt to maximize local control of the disease. Spatially fractionated radiation therapy (GRID) delivers a single-fraction of high dose radiation to these tumors with a curative or palliative goal. GRID therapy may be combined with fractionated radiation therapy or used in a therapeutic multi-modality setting to achieve control of the bulky disease. Current clinical data confirms the value of GRID therapy in the management of large volume of disease with an acceptable toxicity profile. GRID therapy has broad systemic effects leading to increases in a variety of cytokines that correlate with clinical outcome.

Original languageEnglish (US)
Pages (from-to)263-265
Number of pages3
JournalThe Journal of the Arkansas Medical Society
Volume105
Issue number11
StatePublished - May 2009

Fingerprint

Neoplasms
Radiotherapy
Therapeutics
Radiation
Cytokines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Peñagarícano, J. A., Griffin, R., Corry, P., Moros, E., Yan, Y., & Ratanatharathorn, V. (2009). Spatially fractionated (GRID) therapy for large and bulky tumors. The Journal of the Arkansas Medical Society, 105(11), 263-265.

Spatially fractionated (GRID) therapy for large and bulky tumors. / Peñagarícano, José A.; Griffin, Robert; Corry, Peter; Moros, Eduardo; Yan, Yulong; Ratanatharathorn, Vaneerat.

In: The Journal of the Arkansas Medical Society, Vol. 105, No. 11, 05.2009, p. 263-265.

Research output: Contribution to journalArticle

Peñagarícano, JA, Griffin, R, Corry, P, Moros, E, Yan, Y & Ratanatharathorn, V 2009, 'Spatially fractionated (GRID) therapy for large and bulky tumors.', The Journal of the Arkansas Medical Society, vol. 105, no. 11, pp. 263-265.
Peñagarícano JA, Griffin R, Corry P, Moros E, Yan Y, Ratanatharathorn V. Spatially fractionated (GRID) therapy for large and bulky tumors. The Journal of the Arkansas Medical Society. 2009 May;105(11):263-265.
Peñagarícano, José A. ; Griffin, Robert ; Corry, Peter ; Moros, Eduardo ; Yan, Yulong ; Ratanatharathorn, Vaneerat. / Spatially fractionated (GRID) therapy for large and bulky tumors. In: The Journal of the Arkansas Medical Society. 2009 ; Vol. 105, No. 11. pp. 263-265.
@article{eb3d7ea8ab67455aa1ec5d9069d7dd21,
title = "Spatially fractionated (GRID) therapy for large and bulky tumors.",
abstract = "Avanced bulky tumors warrant aggressive therapy to attempt to maximize local control of the disease. Spatially fractionated radiation therapy (GRID) delivers a single-fraction of high dose radiation to these tumors with a curative or palliative goal. GRID therapy may be combined with fractionated radiation therapy or used in a therapeutic multi-modality setting to achieve control of the bulky disease. Current clinical data confirms the value of GRID therapy in the management of large volume of disease with an acceptable toxicity profile. GRID therapy has broad systemic effects leading to increases in a variety of cytokines that correlate with clinical outcome.",
author = "Pe{\~n}agar{\'i}cano, {Jos{\'e} A.} and Robert Griffin and Peter Corry and Eduardo Moros and Yulong Yan and Vaneerat Ratanatharathorn",
year = "2009",
month = "5",
language = "English (US)",
volume = "105",
pages = "263--265",
journal = "The Journal of the Arkansas Medical Society",
issn = "0004-1858",
publisher = "Arkansas Medical Society",
number = "11",

}

TY - JOUR

T1 - Spatially fractionated (GRID) therapy for large and bulky tumors.

AU - Peñagarícano, José A.

AU - Griffin, Robert

AU - Corry, Peter

AU - Moros, Eduardo

AU - Yan, Yulong

AU - Ratanatharathorn, Vaneerat

PY - 2009/5

Y1 - 2009/5

N2 - Avanced bulky tumors warrant aggressive therapy to attempt to maximize local control of the disease. Spatially fractionated radiation therapy (GRID) delivers a single-fraction of high dose radiation to these tumors with a curative or palliative goal. GRID therapy may be combined with fractionated radiation therapy or used in a therapeutic multi-modality setting to achieve control of the bulky disease. Current clinical data confirms the value of GRID therapy in the management of large volume of disease with an acceptable toxicity profile. GRID therapy has broad systemic effects leading to increases in a variety of cytokines that correlate with clinical outcome.

AB - Avanced bulky tumors warrant aggressive therapy to attempt to maximize local control of the disease. Spatially fractionated radiation therapy (GRID) delivers a single-fraction of high dose radiation to these tumors with a curative or palliative goal. GRID therapy may be combined with fractionated radiation therapy or used in a therapeutic multi-modality setting to achieve control of the bulky disease. Current clinical data confirms the value of GRID therapy in the management of large volume of disease with an acceptable toxicity profile. GRID therapy has broad systemic effects leading to increases in a variety of cytokines that correlate with clinical outcome.

UR - http://www.scopus.com/inward/record.url?scp=67649161034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649161034&partnerID=8YFLogxK

M3 - Article

C2 - 19475814

AN - SCOPUS:67649161034

VL - 105

SP - 263

EP - 265

JO - The Journal of the Arkansas Medical Society

JF - The Journal of the Arkansas Medical Society

SN - 0004-1858

IS - 11

ER -